SAB Biotherapeutics, Inc.
SABS· Nasdaq
Released Aug 9, 2021, after the close
10-Q filed Aug 9, 2021, 40 days after period end · 0001493152-21-019063
No earnings release is on file for this quarter. Its figures came with the 10-Q.
no prior Q2 2020 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SAB Biotherapeutics, Inc. · CIK 1833214 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 9, 2021 · 40 d after period end